ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "rheumatoid arthritis"

  • Abstract Number: 0534 • ACR Convergence 2024

    Patient Reported Outcomes and Disease Activity from a Phase 1 Double-Blind Randomized Clinical Trial of Allogeneic Mesenchymal Stem Cells in Early Rheumatoid Arthritis

    Alexandre Matar1, Maya Breitman2, Tracey Bonfield3, Maricela Haghiac4, Jane Reese3, Emma Barnboym5, Steven Lewis6, Hillard Lazarus7 and Nora Singer8, 1MetroHealth, Westlake, OH, 2MetroHealth Medical Center,Case Western Reserve University School of Medicine, Cleveland, OH, 3Case Western Reserve University, Cleveland, OH, 4Metrohealth Medical Center, Cleveland, OH, 5The MetroHealth System, Cleveland, OH, 6Case Western University, MetroHealth, Cleveland, OH, 7Case Western Reserve University/University Hospitals, Cleveland, OH, 8MetroHealth System at Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: Mesenchymal stem (stromal) cells (MSCs) constitute an emerging therapeutic strategy for several human diseases. Small non-randomized studies have shown that MSCs may be a…
  • Abstract Number: 0850 • ACR Convergence 2024

    Assessment of Correlation Between Composite Ultrasonographic Index (ECODAS) and Disease Activity Score 28 in Patients with Rheumatoid Arthritis

    Komal Verma Saluja1, Harshvardhan Khokhar2, Amit Sharma3 and Saurabh Chittora2, 1Government Medical college Kota, Kota, Rajasthan, India, 2Government Medical college Kota, Kota, India, 3Fortis hospital Jaipur, Jaipur, India

    Background/Purpose: Conventional Disease Activity Score 28 has variable sensitivity, subjectivity, inherent bias due to certain variables such as more weightage to joint tenderness and overestimation…
  • Abstract Number: 0906 • ACR Convergence 2024

    Proteomic Signatures of Difficult-to-Treat Rheumatoid Arthritis: Identifying Predictive Biomarkers

    Klára Mocová1, Jiri Baloun1, Aneta Prokopcová2, Kristýna Brábníková Marešová1, Herman Mann3, Jiří Vencovský2, Karel Pavelka4 and Ladislav Šenolt2, 1Institute of Rheumatology, Prague, Czech Republic, 2Institute of Rheumatology and Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, 3Revmatologický ústav, Praha, Czech Republic, 4Institute of Rheumatology and Charles University, Praha, Czech Republic

    Background/Purpose: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by persistent synovial inflammation, progressive joint destruction and extra-articular manifestations. Despite the advancements in the…
  • Abstract Number: 0974 • ACR Convergence 2024

    Number of Days Between Prior Low-dose Weekly Methotrexate Administration and S1-RBD Antibody Response in Adults with Immune Mediated Inflammatory Diseases Vaccinated Against COVID-19: Secondary Analysis of the Vaccine Response On-Off Methotrexate (VROOM) Study Data

    Abhishek Abhishek1, Nicholas Peckham2 and Jonathan Cook2, and the VROOM Study Author Group, 1University of Nottingham, Nottingham, United Kingdom, 2Oxford University, Oxford, United Kingdom

    Background/Purpose: Immunosuppression attenuates immune response to vaccination. A 2-week interruption in low-dose weekly methotrexate immediately after COVID-19 booster improved antibody response to vaccination. There is…
  • Abstract Number: 1023 • ACR Convergence 2024

    Factors Associated with Delays in Dispensation and Insurance Denials of Janus Kinase Inhibitors

    Igor Dombrovsky1, Michael George2, Joshua Baker2 and Thomas Riley3, 1Pennsylvania Hospital, Philadephia, PA, 2University of Pennsylvania, Philadelphia, PA, 3Hopsital of the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Access to Janus kinase inhibitors (JAKi) is controlled by insurance carriers through prior authorizations and the use of restricted formularies. We previously showed that…
  • Abstract Number: 1130 • ACR Convergence 2024

    Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease

    Melanie Hagen1, Laura Bucci1, Sebastian Boeltz2, Danae-Mona Noethling2, Tobias Rothe2, Maria Gabriella Raimondo1, Carlo Tur1, Andreas Wirsching1, Jochen Wacker1, Aline Bozec1, Georg Schett3 and Ricardo Grieshaber-Bouyer1, 1Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Bayern, Germany, 2Department of Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, 3Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany

    Background/Purpose: B-cells and plasma cells are key drivers of systemic autoimmune diseases (AID). Recent data demonstrated preliminary safety and efficacy of using the CD3xCD19 bispecific…
  • Abstract Number: 1332 • ACR Convergence 2024

    Financial Distress and Its Determinants in Adults with Rheumatoid Arthritis

    Amber Brown Keebler1, Yunju Im2, Sofia Pedro3, Ted Mikuls1, Edward Peters1 and Kaleb Michaud1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Omaha, 3Forward, The National Databank for Rheumatic Diseases, Wichita, KS

    Background/Purpose: Often not evaluated in clinical visits, financial distress associated with medical costs, also known as financial toxicity, has emerged as an important factor affecting…
  • Abstract Number: 1348 • ACR Convergence 2024

    Analysis of Body Composition in Patients with Moderate-Severe Rheumatoid Arthritis Treated with Anti-TNF Drugs

    Aimara García-Studer1, Fernando Ortiz-Márquez1, Paula Borregón-Garrido1, Arkaitz Mucientes-Ruiz1, Sara Manrique-Arija1 and Natalia Mena Vázquez2, 1Biomedical Research Institute of Malaga (IBIMA)-Bionand Platform, Department of Rheumatology, Regional University Hospital of Malaga, Malaga, Spain, 2IBIMA, Málaga, Andalucia, Spain

    Background/Purpose: Previous studies have described alterations in fat and lean mass in patients with RA, but the effect of treatments on body composition remains unclear.…
  • Abstract Number: 1364 • ACR Convergence 2024

    Machine Learning-Driven Models for Disease Activity Prediction and Therapeutic Response Evaluation in Rheumatoid Arthritis Patients: An Analysis of Data from the Multicentre, Prospective, Egyptian Collage of Rheumatology (ECR) Study Group

    Nevin Hammam1, Tarek Nahool2, A. M. Yasser3, Eman F Mohamed4, Samar Tharwat5, Doaa Mosad Mosa6, Maha Nassr7, Faten Ismail8, Rawhya R El Shereef8, Nora Y. Elsaid9, Osman Hammam10, Suzan S. Al‑Adle9 and Tamer A Gheita11, 1Rheumatology Department, Faculty of Medicine, Assiut University, Assiut, Egypt, Boston, MA, 2University of the People, Pasadena, CA, USA, Qena, Egypt, 3Physics Department, Faculty of Science, South Valley University, Qena, Egypt; Alchemy Research, Alchemy Global Solutions, Abu Dhabi, UAE, Abu Dhabi, United Arab Emirates, 4Internal Medicine Department, Rheumatology Unit, Faculty of Medicine (Girls), Al-Azhar University, Cairo, Egypt, 5Rheumatology Unit, Internal Medicine, Mansoura University, Dakahlia, 6Rheumatology & Rehabilitation Department, Mansoura University Hospitals, Mansoura University Faculty of Medicine, Egypt, Dakahlia, Egypt, 7Rheumatology Department, Faculty of Medicine, Fayoum University, Fayoum, Egypt, Fayoum, Egypt, 8Rheumatology Department, Faculty of Medicine, Minia University, Minia, Egypt, 9Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt, Cairo, Egypt, 10Department of Rheumatology and Rehabilitation, Faculty of Medicine, New Valley University, New Valley, Assiut, Egypt, 11Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt

    Background/Purpose: Rheumatoid arthritis (RA) often exhibits fluctuating and challenging-to-assess clinical courses that lead to irreversible joint destruction. However, a "Treat-to-Target" strategy is recommended aiming to…
  • Abstract Number: 1380 • ACR Convergence 2024

    Rapid, Clinically Meaningful Pain Improvements Are Associated with Improvements in Other Patient-Reported Outcomes in RA Patients Treated with Upadacitinib

    Manish Jain1, Arthur Kavanaugh2, Angela Crowley3, Avani Joshi4, Patrick Zueger5, Diane Caballero6, Andrew Garrison6 and Peter C. Taylor7, 1Endeavor Health Swedish Hospital and Captain James A, Chicago, IL, 2University of California San Diego, La Jolla, CA, 3Illinois Bone and Joint Institute, Hinsdale Orthopaedics, Hinsdale, IL, 4AbbVie, North Chicago, IL, 5AbbVie Inc, North Chicago, IL, 6AbbVie Inc., North Chicago, IL, 7University of Oxford, Oxford, United Kingdom

    Background/Purpose: Pain is a crucial symptom for patients with RA; early and effective treatment can help alleviate it.1 In this post hoc analysis, we investigated…
  • Abstract Number: 1397 • ACR Convergence 2024

    Temporal Trends in Early Rheumatoid Arthritis (ERA) Patients with Moderate to Severe Disease Activity: A Multicenter Cohort Study of Treatment Strategies and Outcomes in Chinese Patients in the Modern Era

    Yafang Deng1, Chen Yu2, Lin Qiao1, Nan Jiang1, Yanhong Wang3, Xinping Tian1, Qian Wang1, Mengtao Li4 and Xiaofeng Zeng1, 1Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 2Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Dong Cheng Qu, China (People's Republic), 3Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 4Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China 2National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology, Beijing, China

    Background/Purpose: In the contemporary era, the continuous update of international rheumatoid arthritis (RA) guidelines has significantly impacted the diagnosis and management of RA patients in…
  • Abstract Number: 1673 • ACR Convergence 2024

    Assessing the Feasibility of a Mediterranean-Style Diet for Patients with Rheumatoid Arthritis in a Racially and Culturally Diverse Population Across the United States

    Chelsea Thompson1, iazsmin Ventura1, Cuoghi Edens2, Tamiko Katsumoto3 and Sowmya Popuri4, 1Section of Rheumatology, University of Chicago, Chicago, IL, 2Section of Pediatric Rheumatology, Section of Rheumatology, University of Chicago, Chicago, IL, 3Division of Immunology and Rheumatology, Stanford University Medical Center, Palo Alto, CA, 4Section of Internal Medicine, Loyola Medicine MacNeal, Maywood, IL

    Background/Purpose: In 2023, the American College of Rheumatology published a conditional recommendation for patients living with Rheumatoid Arthritis to follow a “Mediterranean style” diet. However,…
  • Abstract Number: 1747 • ACR Convergence 2024

    Native Americans Experience Profound Premature Mortality from Rheumatoid Arthritis

    Parmita Das1, Snehin Rajkumar2, Eric Yen3 and Ram Singh4, 1University of California Los Angeles, Saint Johns, 2UCLA David Geffen School of Medicine, Irvine, CA, 3UCLA, Los Angeles, CA, 4UCLA David Geffen School of Medicine, Los Angeles, CA

    Background/Purpose: Rheumatoid Arthritis (RA) is a chronic debilitating disease affecting up to 1% of the US population and has variable outcomes by race/ethnicity. We analyzed…
  • Abstract Number: 1882 • ACR Convergence 2024

    30-Day Readmission Among Patients with Rheumatoid Arthritis and Their Independent Predictors: Insights from National Readmission Database

    Shobhit Piplani1, Priyanshu Jain2, Vladimir Jelic3, Clement Tagoe4 and Beverly Johnson5, 1Jacobi Medical Center/North Central Bronx Albert Einstein College of Medicine NYC Health and Hospitals, Bronx, NY, 2Jawaharlal Nehru Medical College, Belgaum, Karnataka, India, Bronx, NY, 3Jacobi Medical Center/North Central Bronx, Bronx, NY, 4Albert Einstein College of Medicine, FRESH MEADOWS, NY, 5Albert Einstein College of Medicine, New York, NY

    Background/Purpose: Rheumatoid Arthirits (RA) is associated with heightened morbidity, diminished quality of life, and increased healthcare expenses. This research aims to bridge this gap by…
  • Abstract Number: 1968 • ACR Convergence 2024

    Development and Validation of an Arthritis-Detection Algorithm Using Thermal Imaging in Adults and Children

    Thomason Jenna1, Sullivan Erin2, Rajdeep Pooni3, Liau Adriel4, Sadie Van den Bogaerde5, Audrey Luey6, Iris Hamilton7, Sriya Paluvayi6, Megan Tran1, Janeth Robles-Navarro1, Ian Muse8, Ava Klein4, Tzielan Lee9, Grant Hughes5, Alison Bays5, Elizabeth Ferucci10, Debosmita Biswas11, Savannah Patridge11 and Yongdong (Dan) Zhao12, 1University of Washington, Division of Rheumatology, Seattle, WA, 2Biostatistics, Epidemiology, and Analytics in Research (BEAR) Core, Seattle Children’s Research Institute, Seattle, WA, 3Stanford University, Palo Alto, CA, 4Seattle Children’s Research Institute, University of Washington, Seattle, 5University of Washington, Seattle, WA, 6Seattle Children’s Research Institute, University of Washington, Seattle, WA, 7Seattle Children's Hospital, Seattle, 8Seattle Children's Research institute, Seattle, WA, 9Stanford University School of Medicine, Palo Alto, CA, 10Alaska Native Tribal Health Consortium, Anchorage, AK, 11University of Washington, Department of Radiology, Seattle, WA, 12University of Washington, Redmond, WA

    Background/Purpose: The Thermal imaging-based Temperature After Within-limb Calibration (TAWiC) algorithm for the detection of arthritis in the knees has been validated in children by our…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 188
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology